Search

everythinglearnresearchcommunity

for

Search:↓

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Targeting specific T cells may help treat alopecia areata.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

A patient with sickle cell trait and low vitamin D might have lupus, a rare combination that needs more attention.

Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Targeting CXCL10 may help treat alopecia areata.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

MS patients often have skin issues, so regular skin checks are important.

Etanercept may not prevent alopecia areata from coming back.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Alopecia areata in elderly people is usually mild and responds well to treatment.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

A woman developed a skin condition called Pemphigus Vulgaris after a treatment to help with hair loss.

Certain genes are linked to the risk of developing Alopecia Areata.